The invention relates to the field of pharmaceutical formulations, in particular to 
traditional Chinese medicine for treating gastric ulcers. The 
traditional Chinese medicine is characterized by comprising, by weight, 7-11 parts of sago 
cycas, 7-11 parts of angelica roots, 7-11 parts of 
lithospermum, 3-7 parts of 
pogostemon auricularius, 3-6 parts of golden sealavender flowers, 2-4 parts of radix cynanchi bungei, 2-4 parts of fiveleaf 
gynostemma herbs, 3-6 parts of hairyvein agrimony, 3-5 parts of parameria laevigata, 4-7 parts of 
saruma henryi, 7-10 parts of radix tinosporae, 1-2 parts of 
sandalwood, 3-5 parts of fructus teminaliae billaricae, 3-4 parts of the root of griffith 
streptocaulon, 2-3 parts of sticktight, 1-2 parts of sculellaria barbata, 8-10 parts of biota tops, 3-6 parts of ash 
bark, 2-4 parts of sheeploitered 
azalea, 2-3 parts of 
pseudostellaria maximowicziana and 2-4 parts of 
adiantum. The raw medicinal materials are soaked in water after mixing, and dregs are removed after decoction to obtain a filtrate. The 
traditional Chinese medicine has the advantages that the traditional Chinese 
medicine has double functions of treatment and regulation, the effects of promoting circulation of qi, relieving pain, tonifying the 
spleen, promoting 
digestion, nourishing the heart, tranquilizing the mind, promoting 
blood circulation and stopping bleeding are achieved through pharmaceutical synthesis, and the traditional Chinese 
medicine has good 
curative effect on gastric ulcer treatment.